BVT Aktienanleihe MRK 28.06.2024/ DE000VM1BVJ1 /
2024-05-06 2:05:15 PM | Chg.+0.210 | Bid4:11:12 PM | Ask4:11:12 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
95.490EUR | +0.22% | 95.300 Bid Size: 500,000 |
95.400 Ask Size: 500,000 |
MERCK KGAA O.N. | 160.00 EUR | 2024-06-28 | Call |
GlobeNewswire
2:00 PM
Healthier Capital Founder and Former One Medical CEO Endorses Medeloop Amid Launch of New AI Researc...
GlobeNewswire
1:00 PM
Foghorn Therapeutics Provides First Quarter 2024 Financial and Corporate Update
GlobeNewswire
7:00 AM
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA